Sujit Kumar Bhutia

19PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Host-parasite interactionsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 19, 2026
PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.

|Jul 07, 2026
Targeting lysosomes with a novel chloroquine derivative induces irreversible lysosomal damage and disrupts autophagosome and lysosome assembly in cancer.

|Aug 28, 2025
PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy.

Soumya Ranjan Mishra, Priyadarshini Mishra, Kewal Kumar Mahapatra

|Apr 20, 2025
Age-associated reduction in ER-Mitochondrial contacts impairs mitochondrial lipid metabolism and autophagosome formation in the heart.

Weilong Hong, Xue Zeng, Ruiyan Ma

|Mar 06, 2024
CLU (clusterin) and PPARGC1A/PGC1α coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival.

Prakash P Praharaj, Srimanta Patra, Amruta Singh

|Nov 10, 2023
SIRT1 inhibits mitochondrial hyperfusion associated mito-bulb formation to sensitize oral cancer cells for apoptosis in a mtROS-dependent signalling pathway.

Srimanta Patra, Amruta Singh, Prakash P Praharaj

Pageof 4

Frequent Collaborators

4 joint publications

Daniel J Klionsky

4 joint publications

Prakash Priyadarshi Praharaj

2 joint publications

Debasna P Panigrahi

2 joint publications

Gautam Sethi